精元康胶囊对NP方案化疗治疗非小细胞肺癌减毒作用的观察

目的：观察精元康胶囊配合NP方案化疗治疗非小细胞肺癌（NSCLC）的毒副反应。方法：将40例非小细胞肺癌患者随机分为两组：治疗组20例,用精元康胶囊配合NP方案化疗,对照组20例,单纯用NP方案化疗。结果：治疗组在白细胞减低、恶心呕吐、乏力纳差发生率方面均明显低于对照组,差异有统计学意义（P〈0.05）。结论：精元康胶囊配合NP方案治疗NSCLC患者可减轻毒性反应。

The Clinical Research of Jing Yuan Kang Capsule Combined Chemotherapy on Advanced Stage Nonsmall-cell Lung Cancer

Objective：To observe effect of Jing Yuan Kang Capsule to NSCLC that made use of GP schema. Methods：62 cases were adopted GP schema chemotherapy,32 cases in treatment team was adopted chemotherapy,from the first 3 days to the end of the chemotherapy and in 14 days,add to Jing Yuan Kang capsule,32 cases in control team only was adopted chemotherapy to compare curative effect in the near future,quality of life evaluation after chemotherapy and hematotoxicity reaction in two teams and to carry out correlated data contrast analysis. Results：Comparing to curative effect in the near future of two group,it is similar（ P 0. 05） ,quality of life evaluation of treatment team is better than it of control team,hematotoxicity reaction of treatment is lower than it of control group,contrast is notable（ P 0. 05）. Conclusion：Jing Yuan Kang capsule with chemotherapy on advanced stage NSCLC can improve patient clinical symptom,boost patient quality of life and ease BMD after chemotherapy.